Heming Li | Molecular Biology | Research Excellence Award

Published on by Medical Lab Scientist

Dr. Heming Li | Molecular Biology | Research Excellence Award

Doctor | The first hospital of China Medical University | China

Dr. Heming Li is an oncology clinician-scientist whose research has generated 1,045 citations across 37 scientific documents with an h-index of 17, reflecting a sustained impact on translational cancer science. His work centers on liquid biopsy innovations, particularly circulating tumor cells (CTCs), tumor invasion and metastasis, and immunotherapy biomarkers in lung, gastric, and hepatobiliary cancers. Dr. Li is recognized for pioneering one of China’s earliest and most sensitive cell-surface vimentin (CSV)–based CTC detection platforms, integrating negative and positive enrichment to enhance diagnostic accuracy, reduce costs, and enable real-time monitoring of tumor evolution. His research spans EMT regulation, immune escape, metabolic reprogramming, and multi-omics characterization of metastatic pathways, leading to first-author and corresponding-author publications in high-impact journals such as The Lancet, Journal of Hematology & Oncology, Journal of Experimental & Clinical Cancer Research, Molecular Cancer, Cancer Letters, and Cell Death & Disease. He has elucidated mechanisms including IGF-IR signaling, KDM4A/STAT3-driven tumor progression, ICAM-1-mediated microenvironmental adaptation, and PD-L1 expression on CSV⁺ CTCs as a prognostic marker in gastric cancer. His recent studies have also advanced understanding of FGL1 as an immune checkpoint target and the biological significance of TROP2 in cancer therapeutics. As principal investigator, he has secured major national and provincial funding, including NSFC General and Young Programs, to study CTC-based biomarkers, immunotherapy prediction models, and metastasis-driving pathways. Through sustained contributions across liquid biopsy technology, molecular oncology, and clinically actionable biomarker development, Dr. Li has established a leading research profile shaping the future of precision cancer care.

Profile: Scopus  

Featured Publications

Semiha Yenigun | Biochemistry | Editorial Board Member

Published on by Medical Lab Scientist

Dr. Semiha Yenigun |  Biochemistry | Editorial Board Member

Doctor | University of Ondokuz Mayis | Turkey

Dr. Semiha Yenigün is a distinguished researcher in the field of bioactive natural compounds and medicinal chemistry, with a Ph.D. in Chemistry from Ondokuz Mayıs University, Turkey (2023). Her research primarily focuses on phytochemical analysis, enzyme inhibition, antioxidant mechanisms, and molecular docking studies of plant-derived compounds, particularly from the Nepeta genus and other medicinal species. Dr. Yenigün has extensively explored bioactivity-guided fractionation, DNA protection assays, and in silico molecular dynamics and MM-PBSA analyses to evaluate structure–activity relationships of bioactive molecules. She has co-authored numerous publications in high-impact journals such as the Journal of Biomolecular Structure & Dynamics, ChemistrySelect, and Journal of the Indian Chemical Society. Her studies integrate computational chemistry and experimental biochemistry to identify potential therapeutic agents with antioxidant, antimicrobial, and enzyme inhibitory properties. Dr. Yenigün has contributed significantly to TÜBİTAK-funded projects including investigations on Nepeta baytopii and Elaeagnus umbellata, emphasizing the biotechnological production and characterization of triterpenoids and other phytochemicals. Her scholarly output demonstrates a strong command of molecular modeling, pharmacokinetic analysis, and bioinformatics applications in natural product chemistry, establishing her as an emerging expert in structure-based drug discovery and natural compound bioactivity evaluation.

Profiles: Scopus | ORCID | Google Scholar 

Featured Publications

Bechan Sharma | Biochemistry | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Dr. Bechan Sharma |  Biochemistry | Best Researcher Award

Professor | University of Allahabad | India

Dr. Bechan Indrajit Sharma is a highly accomplished scholar and researcher associated with the University of Allahabad, Prayagraj, India. Over the course of his distinguished career, he has made significant contributions to the fields of biochemistry, molecular biology, and environmental toxicology. His extensive research output includes 171 published documents, reflecting his deep engagement with scientific inquiry and academic excellence. With an impressive total of 5,328 citations  and an h-index of 37, Dr. Sharma has established himself as an influential figure in his area of expertise. His research has not only advanced understanding in critical areas of biological sciences but also addressed important environmental and health-related challenges. Through collaborations with over 300 co-authors, he has fostered interdisciplinary and cross-institutional partnerships, contributing to the global scientific dialogue. Dr. Sharma’s academic journey at the University of Allahabad is marked by his dedication to teaching, mentoring, and guiding young researchers toward innovation and scientific rigor. His work demonstrates a commitment to high-impact research that bridges theory and application, benefiting both academia and society. Known for his meticulous approach and passion for discovery, Dr. Sharma continues to inspire future generations of scientists through his research excellence and leadership in academia. His scholarly achievements and influence make him a prominent voice in the scientific community, reflecting a career devoted to advancing knowledge, fostering collaboration, and promoting sustainable scientific growth on both national and international levels.

Profiles: Scopus | ORCID | Google Scholar 

Featured Publications